Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Google Announces New Health Care A.I. Models
Google Announces New Health Care A.I. Models
Need2Know Biz: Boeing Modifications & Pfizer Forecast
FAA Proposes New Modification for Boeing Planes
U.S. Auto Agency Initiates New Safety Regulations
U.S. Auto Agency Initiates New Safety Regulations
How Traders Are Looking at Consumer Spending, Inflation Data, Mortgage Rates
Eliott Wellenbach, vice president and institutional ETF strategist with Direxion, joined Cheddar News to discuss what traders are expecting from consumer spending ahead of the holidays and how they're positioning themselves following the latest inflation data and mortgage rates.
Apple Unveils New Biometric Security Feature
Apple is testing out a new feature aimed at protecting people's information when thieves have their phones pass code.
Stocks Mixed Ahead of Federal Reserve Rate Decision
Stocks were generally mixed as investors await a decision from the Federal Reserve about interest rates.
'Hallucinate' is Word of the Year
Dictionary.com picked its word of the year: hallucinate.
Report: Best and Worst Tipping States
A report is shedding light on which states are the best and the worst at tipping.
What to Expect During Wednesday's Federal Reserve Meeting
Experts predict the U.S. Federal Reserve will leave rates unchanged during Wednesday's meeting.
